Analysis_NN of_IN intracellular_JJ mobilization_NN suggested_VBD that_IN the_DT signal_NN transduction_NN was_VBD impaired_JJ in_IN cells_NNS ._.
Characterization_NN of_IN a_DT cofactor_NN that_WDT regulates_VBZ dimerization_NN of_IN a_DT mammalian_JJ homeodomain_NN protein_NN ._.
The_DT lymphoid-specific_JJ transcription_NN complex_NN ,_, NF-AT_NN ,_, is_VBZ involved_VBN in_IN early_JJ gene_NN activation_NN in_IN T_NN cells_NNS and_CC is_VBZ assembled_VBN from_IN a_DT pre-existing_JJ ,_, T_NN cell_NN restricted_JJ cytoplasmic_JJ factor_NN and_CC an_DT inducible_JJ ubiquitous_JJ nuclear_JJ component_NN within_IN 30_CD min_NN after_IN activation_NN through_IN the_DT antigen_NN receptor_NN ._.
We_PRP previously_RB identified_VBD a_DT Fas_NN ligand_NN regulatory_JJ element_NN FLRE_NN in_IN the_DT Fas_NN ligand_NN fasL_NN promoter_NN that_IN binds_VBZ Egr_NN family_NN proteins_NNS and_CC demonstrated_VBD that_IN Egr-3_NN PILOT_NN but_CC not_RB Egr-1_NN NGFI-A_NN ,_, Krox-24_NN ,_, Tis-8_NN ,_, and_CC Zif-268_NN induces_VBZ transcription_NN of_IN fasL_NN ._.
In_IN addition_NN ,_, an_DT inhibitor_NN of_IN PKC_NN blocked_VBD both_CC activated_VBD ras_NN and_CC phorbol_NN ester_NN stimulation_NN ,_, suggesting_VBG a_DT role_NN for_IN ras_NN upstream_JJ of_IN PKC_NN ._.
To_TO define_VB the_DT mechanism_NN underlying_VBG signal_NN transducer_NN and_CC activator_NN of_IN transcription_NN STAT_NN protein_NN recruitment_NN to_TO the_DT interleukin_NN 10_CD IL-10_NN receptor_NN ,_, the_DT STAT_NN proteins_NNS activated_VBN by_IN IL-10_NN in_IN different_JJ cell_NN populations_NNS were_VBD first_RB defined_VBN using_VBG electrophoretic_JJ mobility_NN shift_NN assays_NNS ._.
To_TO determine_VB whether_IN the_DT defect_NN in_IN the_DT patient_NN T_NN lymphocytes_NNS involved_VBD a_DT trans-acting_JJ factor_NN common_JJ to_TO the_DT affected_VBN lymphokine_NN genes_NNS ,_, we_PRP examined_VBD the_DT ability_NN of_IN nuclear_JJ factors_NNS from_IN the_DT patient_NN T_NN lymphocytes_NNS to_TO bind_VB response_NN elements_NNS present_JJ in_IN the_DT regulatory_JJ region_NN of_IN IL2_NN ._.
Two_CD subclones_NNS were_VBD found_VBN to_TO have_VB an_DT abnormal_JJ response_NN to_TO the_DT protein_NN kinase_NN C_NN PKC_NN activator_NN PMA_NN ._.
U1_NN lines_NNS overexpressing_VBG activator_NN NF-IL-6_NN produced_VBD more_JJR viral_JJ mRNA_NN and_CC virus_NN particles_NNS following_VBG cellular_JJ activation_NN than_IN control_NN lines_NNS ,_, demonstrating_VBG that_IN proteins_NNS are_VBP limiting_VBG for_IN virus_NN transcription_NN ._.
Butyric_JJ acid_NN BA_NN is_VBZ known_VBN to_TO induce_VB overexpression_NN of_IN fetal_JJ hemoglobin_NN and_CC then_RB erythroid_JJ differentiation_NN ._.
Two_CD unrearranged_JJ TcR_NN delta_NN transcripts_NNS had_VBD a_DT size_NN similar_JJ to_TO that_DT of_IN the_DT functional_JJ TcR_NN delta_NN mRNA_NN 2.3_CD and_CC 1.3_CD kb_NN found_VBN in_IN TcR_NN T_NN lymphocytes_NNS ._.
In_IN agreement_NN with_IN this_DT finding_NN ,_, Northern_NN experiments_NNS where_WRB p65_NN and_CC p105_NN mRNA_NN levels_NNS were_VBD determined_VBN ,_, demonstrated_VBD that_IN expression_NN of_IN these_DT components_NNS of_IN the_DT NF-kappa_NN B_NN transcription_NN factor_NN were_VBD not_RB affected_VBN by_IN IL-10_NN or_CC IL-4_NN ._.
How_WRB does_VBZ GATA-1_NN regulate_VB red_JJ cell_NN genes_NNS like_IN globin_NN or_CC the_DT Epo_NN receptor_NN
In_IN contrast_NN ,_, expression_NN of_IN the_DT activation-dependent_JJ cell_NN surface_NN markers_NNS CD25_NN and_CC CD69_NN was_VBD within_IN normal_JJ limits_NNS ._.
Therefore_RB ,_, it_PRP is_VBZ important_JJ to_TO determine_VB whether_IN CD14_NN is_VBZ expressed_VBN in_IN gingival_JJ fibroblasts_NNS and_CC to_TO define_VB the_DT P-LPS-mediated_JJ signal-transducing_JJ mechanism_NN in_IN the_DT cells_NNS ._.
Gel_NN retardation_NN and_CC methylation_NN interference_NN studies_NNS revealed_VBD that_IN bacterially_RB produced_VBN AP-2_NN bound_VBD specifically_RB and_CC with_IN high_JJ affinity_NN to_TO all_DT three_CD 21_CD bp_NN repeats_NNS ,_, and_CC that_IN it_PRP required_VBD the_DT core_NN sequence_NN AGGC_NN for_IN specific_JJ binding_NN ._.
We_PRP analyzed_VBD the_DT effects_NNS of_IN hemin_NN or_CC TPA_NN induction_NN on_IN the_DT binding_NN and_CC activity_NN of_IN transcription_NN factors_NNS at_IN a_DT regulatory_JJ element_NN found_VBN within_IN the_DT transcriptional_JJ regulatory_JJ sequences_NNS of_IN many_JJ erythroid-specific_JJ genes_NNS ._.
Tissue_NN specific_JJ regulation_NN of_IN gene_NN expression_NN by_IN transcription_NN factors_NNS is_VBZ a_DT fascinating_JJ new_JJ field_NN in_IN molecular_JJ immunology_NN ._.
In_IN this_DT report_NN ,_, it_PRP is_VBZ demonstrated_VBN that_IN Elf-1_NN contains_VBZ a_DT sequence_NN motif_NN that_WDT is_VBZ highly_RB related_JJ to_TO the_DT Rb_NN binding_NN sites_NNS of_IN several_JJ viral_JJ oncoproteins_NNS and_CC binds_VBZ to_TO the_DT pocket_NN region_NN of_IN Rb_NN both_CC in_FW vitro_FW and_CC in_FW vivo_FW ._.
In_IN this_DT report_NN ,_, we_PRP describe_VBP the_DT phenotype_NN of_IN mouse_NN transgenic_JJ lines_NNS obtained_VBN by_IN inducing_VBG tal-1_NN protein_NN expression_NN in_IN lymphoid_JJ tissues_NNS using_VBG the_DT LCK_NN promoter_NN ._.
Although_IN ,_, the_DT level_NN of_IN MNDA_NN mRNA_NN in_IN primary_JJ monocytes_NNS is_VBZ very_RB low_JJ it_PRP was_VBD up-regulated_VBN at_IN 6_CD h_NN following_VBG the_DT addition_NN of_IN interferon_NN alpha_NN ._.
We_PRP have_VBP found_VBN that_IN purified_VBN human_JJ peripheral-blood_JJ granulocytes_NNS express_VBP constitutively_RB significant_JJ levels_NNS of_IN proto-oncogenes_NNS c-jun_NN ,_, jun_NN B_NN and_CC jun_NN D_NN mRNA_NN ._.
A_DT dominant_JJ inhibitory_JJ ras_NN mutant_NN specifically_RB blocked_VBD antigen_NN receptor_NN agonism_NN ,_, indicating_VBG that_IN ras_NN activity_NN is_VBZ required_VBN for_IN antigen_NN receptor_NN signaling_NN ._.
This_DT induction_NN of_IN CAT_NN activity_NN was_VBD sensitive_JJ to_TO dexamethasone_NN ._.
We_PRP also_RB showed_VBD that_IN this_DT silencer_NN has_VBZ stronger_JJR inhibitory_JJ activity_NN in_IN HeLa_NN cells_NNS ,_, as_IN compared_VBN to_TO K562_NN human_JJ erythroleukemia_NN cells_NNS ._.
